Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
Anything in particular you want to know about the shots
Some protocols involve continuous administration for 6-12 months with periodic assessment and dose adjustment
This is a research chemical supplied for in-vitro use only and is not for human or veterinary administration
US$ 19.99
US$ 29.84
US$ 21.70
